Relationship of urinary kallikrein excretion to urinary potassium excretion during furosemide administration with and without amiloride.
The relationship of urinary kallikrein excretion to urine volume, and to urinary sodium and potassium excretions was studied in normal rats during furosemide diuresis and superimposed injection of amiloride, a K+-sparing diuretic. Continuous infusion of furosemide increased urinary kallikrein, sodium and potassium excretions and the urine volume. Amiloride injection during furosemide diuresis caused further increase in diuresis and natriuresis, but a prompt decrease in urinary kallikrein excretion to basal level, and potassium excretion to below the basal level. The significant correlation of urinary kallikrein excretion to urinary potassium excretion, but not to urine volume and urinary sodium excretion after amiloride injection suggests that the major determinant of urinary kallikrein excretion is renal potassium secretion through a mechanism that is affected by amiloride.
D000584:Amiloride / Q000494:pharmacology*; D000818:Animals; D004231:Diuresis / Q000187:drug effects; D005665:Furosemide / Q000494:pharmacology*; D007610:Kallikreins / Q000652:urine*; D008297:Male; D011188:Potassium / Q000652:urine*; D051381:Rats; D012964:Sodium / Q000652:urine
D000584:Amiloride; D005665:Furosemide; D012964:Sodium; D007610:Kallikreins; D011188:Potassium